CD19 and rheumatoid arthritis: Of relevance, we have recently demonstrated that up to 40% of recombinant monoclonal antibodies derived from single CD19+ synovial tissue cells (RA-syn-rmAbs) obtained from ACPA+ RA patients with functional ectopic GC display reactivity toward citrullinated histones (75).